Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-07-01 @ 2:58 AM
Study NCT ID:
NCT01222520
Status:
COMPLETED
Last Update Posted:
2014-06-27
First Post:
2010-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Telmisartan 80mg Non-responder Trial
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1235.36
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None